Analytical Method Change for Neuravastatin. Manufacturing Process Change for Neuravastatin — routine update. Impacts 5 markets and 4 variations.

Change Number
CHG-2022-0247
Type
Analytical Method Change
Status
Pending
Owner
Marcus Webb
Initiated
2024-01-24
Description

Manufacturing Process Change for Neuravastatin — routine update

Impacted Markets (5)
CA — CanadaGB — United KingdomMX — MexicoPL — PolandAT — Austria
Impacted Modules
4.2.15.3.52.3.P3.2.S
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved